Understanding the Connection Between Common Stroke Comorbidities, Their Associated Inflammation, and the Course of the Cerebral Ischemia/Reperfusion CascadeFRONTIERS IN IMMUNOLOGYIF5.92021-11-15102OAAI
Ligands of the Neuropeptide Y Y2 Receptors as a Potential Multitarget Therapeutic Approach for the Protection of the Neurovascular Unit Against Acute Ischemia/Reperfusion: View from the Perspective of the Laboratory BenchTRANSLATIONAL STROKE RESEARCHIF4.32021-07-225OAAI
Neuroprotective effect of the group III mGlu receptor agonist ACPT-I after ischemic stroke in rats with essential hypertensionPROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYIF3.92018-06-0117PREAI
Intraoperative assessment of cerebral blood flow changes in normal and pathological brain tissue using an infrared cameraQUANTITATIVE INFRARED THERMOGRAPHY JOURNALIF4.92018-03-202PREAI
ACPT-I, a group III mGlu receptor agonist, reduces infarction and behavioral deficit in normotensive and spontaneously hypertensive rats subjected to transient focal cerebral ischemiaPHARMACOLOGICAL REPORTSIF3.82015-09-010PREAI
Sphingosine kinase 1 mediated signalling in Parkinson's disease animal model. Neuroprotective effect of fingolimod and a D2/D3 dopamine receptor agonistEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72015-09-011PREAI